University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB), doing business as U A B, is a public research university and academic medical center that has received numerous federal contract and grant awards. As a leading research institution, UAB provides a wide range of goods and services to the federal government, including biomedical research, healthcare services, engineering solutions, and aerospace support. UAB is known for its expertise in areas such as cancer research, infectious diseases, neuroscience, and cardiovascular medicine. The university has a strong track record of securing federal funding to advance scientific knowledge and improve public health outcomes.
Through federal contracts, UAB has provided various goods and services across multiple agencies. The university has conducted research for the Department of Defense on topics like trauma resuscitation and blood products for battlefield applications. UAB has also supported NASA's Johnson Space Center through an Indefinite Delivery Contract for research, engineering, and mission integration services related to the International Space Station Program. Additionally, the university has performed work for the Consumer Product Safety Commission to collect data on consumer product-related injuries. UAB has served as both a prime contractor and subcontractor on federal projects, leveraging its diverse capabilities in biomedical engineering, advanced manufacturing, and aerospace support. While many of UAB's contract awards do not have set-aside designations, the university's extensive experience and specialized expertise have made it a valuable partner for federal agencies seeking innovative solutions to complex challenges.
UAB's federal grant portfolio showcases its strength in biomedical and health-related research. The university has received numerous awards from the National Institutes of Health (NIH) to study a wide range of topics, including cancer biology, cardiovascular diseases, neurodegenerative disorders, and infectious diseases. For example, UAB has conducted research on novel therapeutic approaches for triple-negative breast cancer, investigated the role of specific proteins in Alzheimer's disease, and explored new strategies for HIV prevention and treatment. The university has also received grants from the National Science Foundation to advance knowledge in areas such as materials science, data analytics, and STEM education. Many of UAB's grant projects involve collaboration with other institutions, reflecting its commitment to interdisciplinary research and knowledge sharing. As both a prime recipient and subrecipient of federal grants, UAB has demonstrated its ability to lead large-scale research initiatives and contribute specialized expertise to multi-institutional projects.
In January 2024, UAB was awarded a significant Indefinite Delivery Contract (IDC) by NASA's Johnson Space Center for the Research, Engineering, and Mission Integration Services 2 (REMIS2) program. This multiple-award IDC has a potential value of $478 million and runs through September 2030. Under this contract, UAB will provide a range of services including spaceflight and ground hardware and software development, sustaining engineering functions, payload facility integration, and research mission integration and operations support for the International Space Station Program. This award underscores UAB's capabilities in aerospace and engineering, positioning the university as a key partner in NASA's ongoing space exploration efforts. The REMIS2 contract demonstrates UAB's ability to secure and manage large-scale, complex federal projects that require multidisciplinary expertise and innovative solutions.
YND4PLMC9AN7 541715
Not listed Restricted Parking, 701 20th St S, Birmingham, AL 35294, USA
6/29/99 8/13/25 Emory University
Emory University, a private research institution in Atlanta, Georgia, is a major recipient of federal contract and grant awards through its Office of Sponsored Programs Division. As one of the nation's leading academic and research centers, Emory provides a wide range of services to the federal government, primarily in the areas of biomedical research, public health, and clinical studies. The university has an extensive track record of conducting federally funded research across various disciplines, including infectious diseases, cancer, neuroscience, and environmental health. Emory's expertise and resources make it a valuable partner for government agencies seeking to advance scientific knowledge and improve public health outcomes.
Through federal contract awards, Emory University has provided a diverse array of goods and services to government agencies. These include conducting clinical trials for new vaccines and therapeutics, developing diagnostic tools for infectious diseases, and performing advanced biomedical research. The university has received contracts from agencies such as the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and the Department of Defense (DoD). Notable contract work includes studies on HIV/AIDS, influenza, and emerging infectious diseases. Emory has also been involved in contracts related to public health emergency preparedness and response, leveraging its expertise in epidemiology and infectious disease management. Many of these contracts are awarded directly to Emory as the prime contractor, though the university also frequently collaborates with other institutions and private sector partners as a subcontractor.
Emory University's federal grant portfolio is extensive and covers a wide range of research areas. The university receives substantial funding from various NIH institutes, including the National Institute of Allergy and Infectious Diseases, National Cancer Institute, and National Institute of Mental Health. These grants support cutting-edge research in areas such as HIV/AIDS, cancer biology, neurodegenerative diseases, and mental health disorders. Emory also receives grants from other federal agencies, including the National Science Foundation for basic science research and the Health Resources and Services Administration for healthcare workforce development. The university often serves as the prime recipient on these grants, leading large-scale research projects and clinical studies. Additionally, Emory frequently collaborates with other academic institutions, healthcare organizations, and community partners on grant-funded projects, serving as either the lead institution or a subrecipient.
Emory University holds a significant Indefinite Delivery Contract (IDC) with the National Institute of Allergy and Infectious Diseases (NIAID) for the development and refinement of pre-clinical models of infectious diseases. This IDC, with a ceiling value of $146,300,000 and a performance period through July 2031, enables Emory to provide NIAID with the capability to develop, refine, and employ various animal models for studying infectious diseases. The contract covers work on small animal models, non-human primate models, animal replacement models, and non-traditional animal models. It also includes evaluating the efficacy, safety, pharmacokinetics, and pharmacodynamics of candidate countermeasures such as therapeutics, vaccines, and diagnostics against a wide range of infectious agents, including those with pandemic potential and drug-resistant pathogens. This IDC positions Emory as a key partner in NIAID's efforts to advance the development of medical countermeasures against infectious diseases.
S352L5PJLMP8 611310
Not listed 201 Dowman Dr, Atlanta, GA 30322, USA
9/21/01 5/3/25 Rector & Visitors Of The University Of Virginia
Rector & Visitors Of The University Of Virginia, doing business as University of Virginia (UVA), is a public research university and leading academic institution that provides a wide range of goods and services to the federal government through contracts and grants. As a major research university, UVA conducts cutting-edge research and development across numerous scientific and technical domains. The university leverages its expertise in areas such as medicine, engineering, data science, and policy to advance federal priorities and address national challenges. UVA has extensive experience managing complex federally-funded projects and collaborating with government agencies, other academic institutions, and industry partners.
Through federal contracts, UVA provides research, engineering, analysis, and technical services to agencies like the Department of Defense, NASA, and the National Institutes of Health. Notable contract awards include a $2.9 million grant from the Army Research Office to explore applications of stable homotopy theory in areas like geometric topology and number theory. UVA also received a $586,419 award from the Office of Naval Research to construct a world-class water channel facility for naval hydrodynamics research. Additionally, the university was awarded $728,403 from the Air Force Research Laboratory to develop high-speed imaging systems for studying biofabricated nanomaterials. UVA frequently serves as both a prime contractor and subcontractor on defense and civilian agency contracts, often collaborating with industry partners and other universities.
UVA's federal grant portfolio spans a diverse range of research areas and federal programs. The university has received numerous multi-million dollar grants from the National Institutes of Health to study topics like cardiovascular disease, cancer, infectious diseases, and neurological disorders. For example, UVA was awarded a $754,391 grant from NIDA to study the effects of e-cigarette use on lung health using advanced imaging techniques. The National Science Foundation has provided grants to UVA for research in areas like quantum computing, artificial intelligence, and advanced manufacturing. UVA also participates in major multi-institutional research initiatives funded by agencies like NASA, the Department of Energy, and DARPA. The university frequently collaborates with other academic institutions as both a prime recipient and sub-awardee on federal grants.
UVA holds an indefinite delivery contract from the National Highway Traffic Safety Administration to support the Crash Injury Research and Engineering Network (CIREN) program. This IDV has a potential value of $1.9 million over five years. Under this vehicle, UVA has received multiple delivery orders to conduct research aimed at reducing motor vehicle crashes and injuries. The work involves collecting and analyzing crash investigation data to inform the development of improved vehicle safety standards. UVA leverages its expertise in areas like biomechanics and injury prevention to support NHTSA's mission through this IDV. The university has not received any other major IDV awards in recent years based on the information provided.
JJG6HU8PA4S5 611310
Not listed 1001 Emmet St N, Charlottesville, VA 22903, USA
11/20/01 8/23/25 Inova Health Care Services
Inova Health Care Services, operating as Inova Fairfax Hospital, is a corporate tax-exempt hospital and non-profit organization providing comprehensive healthcare services to over 2 million patients annually in the Washington D.C. metro area. As a federal contractor and grantee, Inova offers a wide range of medical services, supplies, and research support to various government agencies. The organization has demonstrated capabilities in patient care, clinical trials, biospecimen collection and analysis, community health programs, and specialized medical services like forensic examinations. Inova maintains active registrations in federal procurement systems and holds multiple ongoing contracts and grants with defense and civilian agencies.
Through federal contract awards, Inova Health Care Services has provided diverse medical goods and services as both a prime contractor and subcontractor. As a prime, Inova has supplied blood and blood products to the Defense Health Agency, furnished patient hospitalization and care services to the NIH Clinical Center, and delivered medical instruments and supplies to the Department of State Bureau of Medical Services. The organization has also conducted crash injury research for the National Highway Traffic Safety Administration. As a subcontractor, Inova has contributed to population health research efforts led by the University of Utah. Notably, these contract awards have not utilized small business set-asides, reflecting Inova's status as a large healthcare provider. Key civilian agency partners include the Department of Health and Human Services and Department of State, while defense contracts have primarily involved the Defense Health Agency.
Inova Health Care Services has secured numerous federal grants and subgrants to advance medical research, enhance patient care, and support public health initiatives. As a prime grantee, Inova has received funding from the National Institutes of Health for studies on diabetes in pregnancy, HIV prevention and care, cardiac biomarkers, and pediatric research. The organization has also obtained grants from the Food and Drug Administration to improve heart failure research collaboration. Additionally, Inova implements HIV/AIDS education and service programs funded by the Health Resources and Services Administration. As a subgrantee, Inova has contributed to multi-site clinical trials, proteomics research, and translational science programs led by academic institutions like Georgetown University, University of Virginia, and Ohio State University. These collaborative efforts have addressed diverse health topics including cancer, HIV/AIDS, celiac disease, and COVID-19.
Inova Health Care Services holds two notable indefinite delivery contracts that facilitate ongoing service provision to federal agencies. The first is a $14.5 million single-award IDC from the Department of State Bureau of Medical Services for medical and vaccination support services. Under this vehicle, Inova has received multiple delivery orders for medical instruments, supplies, and general healthcare services to support State Department personnel domestically and abroad. The second is a $2.25 million single-award IDC from the National Highway Traffic Safety Administration to support the Crash Injury Research and Engineering Network (CIREN) program. This contract enables Inova to provide ongoing research contributions and enrollment services for NHTSA's crash injury studies through August 2027. These IDVs demonstrate Inova's capacity to maintain long-term contractual relationships and deliver consistent, specialized services to meet federal agency needs.
WQCEDBM284L6 622110
Not listed 8095 Innovation Park Dr, Fairfax, VA 22031, USA
11/23/04 9/30/25 University Of Maryland, Baltimore
The University of Maryland, Baltimore (UMB), doing business as Baltimore Campus, is a major public research university and the founding campus of the University System of Maryland. As a leading academic health, law, and human services institution, UMB receives substantial federal funding through contracts and grants to support its research, education, and clinical activities. The university provides a wide range of goods and services to the federal government, including biomedical and clinical research, healthcare services, professional education and training, and community outreach programs. UMB's expertise spans diverse fields such as medicine, nursing, pharmacy, dentistry, law, and social work.
Through federal contract awards, UMB has provided various goods and services to government agencies. These include conducting clinical trials and medical research for the National Institutes of Health (NIH) and Department of Defense, supplying laboratory reagents and services to Veterans Affairs medical centers, delivering healthcare professional education for military personnel, and providing cadavers for medical training at the Uniformed Services University. UMB has also received contracts for parking services, administrative support, and environmental exposure exams. The university often serves as the prime contractor on these awards, which are typically executed without set-aside designations. Key contracting agencies include the Department of Veterans Affairs, NIH, Department of Defense, and Navy.
UMB's federal grant portfolio is extensive and diverse, reflecting its status as a major biomedical research institution. The university receives numerous R01, U01, and other research project grants from NIH institutes to study topics such as infectious diseases, cancer, neuroscience, aging, and drug abuse. UMB also participates in large, multi-site clinical research networks and trials funded by NIH. Additionally, the university receives training grants to support graduate students and postdoctoral researchers. Beyond NIH, UMB has grants from other agencies like the Department of Defense, Centers for Disease Control and Prevention, and Health Resources and Services Administration to support various health-related research and education initiatives. The university often collaborates with other academic institutions, healthcare organizations, and community partners on these grant-funded projects.
UMB holds two significant federal contract Indefinite Delivery Vehicles (IDVs). The first is a $6 million Blanket Purchase Agreement awarded by the Department of Veterans Affairs to provide reagents, supplies, laboratory services, instrumentation, and veterinary care services for VA research through October 2028. The second is a $245,000 Blanket Purchase Agreement from the Department of Defense's Uniformed Services University to supply cadavers for medical education and research programs through June 2028. These IDVs allow the respective agencies to place orders for these goods and services from UMB as needed over multi-year periods, providing a streamlined procurement mechanism for ongoing collaborations between UMB and these federal partners in support of medical research and education.
Z9CRZKD42ZT1 611310
Not listed 220 N Arch St, Baltimore, MD 21201, USA
3/18/02 1/2/26